CLOV Stock Analysis: Buy, Sell, or Hold?
CLOV - Clover Health Investments, Corp
$2.24
-0.03 (-1.32%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When CLOV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
4 traders called CLOV this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CLOV is down 13.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CLOV is down 13.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CLOV is currently trading at $2.24, which is considered oversold relative to its 30-day fair value range of $2.39 to $2.64. From a valuation perspective, the stock is trading at a discount (Forward PE: 37.8) compared to its historical average (42.4). Remarkably, the market is currently pricing in an annual earnings decline of 3.7% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CLOV is in a downtrend. The price is currently testing key support at $2.21. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.23 (+42.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CLOV is in a downtrend. The price is currently testing key support at $2.21. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.23 (+42.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$2.39 -
$2.64
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding CLOV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 42.4% below Wall St target ($3.23)
- WARNING: Recommendation downgraded due to -13.5% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$2.39 -
$2.64
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$2.21
Resistance Level
$2.73
Current Trend
Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
37.83
Wall Street Target
$3.23
(+42.4%)
Revenue Growth (YoY)
50.1%
Profit Margin
-3.3%
Valuation Discount vs History
-3.7% cheaper
PE vs Historical
37.8 vs 42.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-3.7%
(market-implied from PE analysis)
1-Year Target
$2.19
(-4%)
2-Year Target
$2.11
(-7%)
3-Year Target
$2.03
(-11%)
3-Yr Target (if PE normalizes)
(PE: 38→42)
$2.27
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 37.8, Growth: 50.0%)
$7.66
(+238%)
Base:
(SPY PE: 22.3, Growth: 50.0%)
$4.52
(+99%)
Bear:
(PE: 19.0, Growth: 50.0%)
$3.84
(+69%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 37.8 to 42.4
Stabilization Target:
$2.54
(+12.1%)
PE Expansion Potential:
+12.1%
Last updated: January 31, 2026 3:24 AM ET
Data refreshes hourly during market hours. Next update: 4:24 AM
Data refreshes hourly during market hours. Next update: 4:24 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLOV showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Anna U Loengard
BUY
26500 shares
2025-08-13
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$95 | 61 BUY |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$327 | 58 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$394 | 47 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$395 | 53 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$288 | 62 BUY |
Advanced CLOV Option Strategies
Professional options setups generated by AI based on today's CLOV price and gamma walls.
